| Q38705413 | 1-cyclohexyl-x-methoxybenzene derivatives, novel psychoactive substances seized on the internet market. Synthesis and in vivo pharmacological studies in mice. |
| Q39569585 | 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry |
| Q38705409 | 4,4'-Dimethylaminorex ("4,4'-DMAR"; "Serotoni") misuse: A Web-based study. |
| Q38382285 | 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4'-DMAR, 4,4'-dimethylaminorex): availability, prevalence of use, desired effects and acute toxicity |
| Q38588258 | A Case Review of the First Analytically Confirmed 25I-NBOMe-Related Death in Washington State |
| Q34674320 | Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions |
| Q92012025 | Acute Limb Ischemia after Intake of the Phenylethylamine Derivate NBOMe |
| Q26784276 | Adverse Psychiatric Effects Associated with Herbal Weight-Loss Products |
| Q45881546 | An insight into the deep web; why it matters for addiction psychiatry? |
| Q42156143 | Analysis of 25 C NBOMe in Seized Blotters by HPTLC and GC-MS. |
| Q53137811 | Blunt Craniofacial Trauma as a Manifestation of Excited Delirium Caused by New Psychoactive Substances. |
| Q48346962 | Can mobile phone technology support a rapid sharing of information on novel psychoactive substances among health and other professionals internationally? |
| Q38950359 | Cannabis and development of dual diagnoses: A literature review |
| Q48721685 | Detection of 25C-NBOMe in Three Related Cases |
| Q35575147 | Drug abuse, relapse, and prevention education in malaysia: perspective of university students through a mixed methods approach |
| Q38608674 | Drunkorexia: an emerging trend in young adults. |
| Q90047720 | Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances |
| Q34504233 | Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries |
| Q55080181 | Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives. |
| Q52760538 | LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening pow |
| Q38985251 | MDMB-CHMICA: Availability, Patterns of Use, and Toxicity Associated With This Novel Psychoactive Substance. |
| Q90344547 | NBOMes-Highly Potent and Toxic Alternatives of LSD |
| Q26752739 | Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants |
| Q34667835 | Novel psychoactive substances of interest for psychiatry. |
| Q30251771 | Novel psychoactive substances: the pharmacology of stimulants and hallucinogens. |
| Q40300263 | Novel psychoactive substances: use and knowledge among adolescents and young adults in urban and rural areas |
| Q38768825 | Oral fluid drug analysis in the age of new psychoactive substances |
| Q36209103 | Patterns of Substance Use Across the First Year of College and Associated Risk Factors |
| Q90139030 | Quick Test for Determination of N-Bombs (Phenethylamine Derivatives, NBOMe) Using High-Performance Liquid Chromatography: A Comparison between Photodiode Array and Amperometric Detection |
| Q48060529 | Something New about Something Old: A 10-Year Follow-Up on Classical and New Psychoactive Tryptamines and Results of Analysis. |
| Q26865329 | Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature |